_revolutionary-prion-early-detection-science.jpg "Revolutionary Prion Early Detection Science from and prion com Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 20 sec
✓ Published: 03-Jan-2018
✓ Published: 03-Jan-2018
Description:
In this video, Dr. Claudio Soto—CSO of Amprion—explains the breakthrough science behind Amprion's Prion Early Detection technology for Alzheimer's, Parkinson's, and other neurodegenerative diseases.Find out what causes Alzheimer's and Parkinson's, and why early detection prior to the start of any clinical symptoms have been so challenging. We believe early detection at the molecular level gives us 20/20 vision to track the biomarkers—Prions— that cause, and drive, the progression of th
In this video, Dr. Claudio Soto—CSO of Amprion—explains the breakthrough science behind Amprion's Prion Early Detection technology for Alzheimer's, Parkinson's, and other neurodegenerative diseases.Find out what causes Alzheimer's and Parkinson's, and why early detection prior to the start of any clinical symptoms have been so challenging. We believe early detection at the molecular level gives us 20/20 vision to track the biomarkers—Prions— that cause, and drive, the progression of th
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_prion-disease.webp "UCSF Memory and Aging Center")
_the-amprion-story.webp "Discover why early diagnosis for Alzheimer’s and Parkinson’s has been so challenging until now. And why fighting Alzheimer's disease is critically important on a global scale. Meet Amprion, a biotech company with groundbreaking Early Detection science to track the biomarkers (aka prion-particles or misfolded proteins) that cause these neurodegenerative diseases. Amprion's revolutionary early detection technology tracks all three misfolded proteins: Abeta amyloid, Tau and Synuclein prior to a")
_prions-and-the-disease-of-the-dead.webp "ScienceWorld")
_prions-the-misfolding-proteins-that-create-uncurbable-diseases.webp "Into the Shadows")
_prion-protein-and-prion-disease.webp "Shomu's Biology")
_prion-disease-animation.webp "Nanobot Scientific Communication")
_amprion-accelerates-drug-development.webp "Why has there been no effective treatment for Alzheimer’s and Parkinson’s despite over $100 billion spent in drug development and clinical trials over the past three decades? Find out why effective drug development has been so challenging for pharmaceutical companies. Amprion, a biotech company with revolutionary Prion Early Detection Testing(sm) for Alzheimer’s and Parkinson’s is poised to change the game. Through our groundbreaking technology, we can now track the biomarkers—Prions")
_the-disease-you-will-never-survive.webp "MinuteEarth")
_prion-disease.jpg)
_the-amprion-story.jpg)
_prions-and-the-disease-of-the-dead.jpg)
_prions-the-misfolding-proteins-that-create-uncurbable-diseases.jpg)
_prion-protein-and-prion-disease.jpg)
_prion-disease-animation.jpg)
_amprion-accelerates-drug-development.jpg)
_the-disease-you-will-never-survive.jpg)
![[+]](/images/menu.gif){kind=small}